CUSIP 87164F105COMSNDXQ4 2025
63 filings · latest Feb 9, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 8.24M | $173.10M |
| 2 | Kynam Capital Management, LP | 8.05M | $169.15M |
| 3 | Vanguard Group Inc | 6.23M | $130.90M |
| 4 | Goldman Sachs Group Inc | 5.70M | $119.66M |
| 5 | Point72 Asset Management, L.P. | 4.88M | $102.57M |
| 6 | Bank Of America Corp /De/ | 4.71M | $98.97M |
| 7 | State Street Corp | 4.60M | $96.57M |
| 8 | Eversept Partners, LP | 3.31M | $69.64M |
| 9 |
| 4 | Aug 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 2.7% | 2.31M | SEC |
| 5 | Aug 13, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 5.58M | SEC |
| 6 | May 9, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 4.51M | SEC |
| 7 | May 7, 2025 | Morgan Stanley | 13G/A | 2.4% | 2.04M | SEC |
| 8 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.8% | 6.74M | SEC |
| 9 | Mar 7, 2025 | Wellington Management Group LLP | 13G/A | 0.0% | 35.7K | SEC |
| 10 | Feb 14, 2025 | Kynam Capital Management, LP | 13G/A | 10.0% | 8.52M | SEC |
See the full Schedule 13D/13G history for Syndax Pharmaceuticals Inc.
Unlock full history| 2.42M |
| $50.88M |
| 10 | Kingdon Capital Management, L.L.C. | 2.35M | $49.37M |